Project Grant R44HD118899
Award Date
4/15/25
Completion Date
3/31/28
Dollars Obligated
$760K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Nextgenjane Inc. (EWN3LW7S8NP5)
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute of Child Health and Human Development (NICHD) awarded a $2,045,782 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Endomet Biosciences, Inc., a woman-owned small business located in Irvine, California. The grant aims to develop ENDO-205, a novel, non-hormonal therapeutic for the treatment of endometriosis, a prevalent and debilitating gynecological condition affecting approximately 10% of women worldwide. The project will advance...
The National Institute of Child Health and Human Development (NICHD) awarded a $717,871 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the Magee-Womens Research Institute and Foundation in Pittsburgh, PA. The grant, which runs from August 2024 to July 2029, aims to develop epigenomic liquid biopsy methods for early detection and prediction of preterm birth, preeclampsia, and intrauterine growth restriction. The project will leverage cell-free DNA analysis...
This Project Grant award, funded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to characterize the epigenetic and genetic mechanisms underlying different stages of endometriosis. The award of $731,893 to the University of Texas Health Science Center at San Antonio will support large-scale single-cell epigenomic profiling to understand disrupted gene regulation in low and high-stage...
This Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to identify the underlying mechanisms of pain in endometriosis. The $233,250 award to The Washington University in St. Louis will support a 2-year study to examine both central and peripheral factors contributing to endometriosis pain, including inhibitory pain modulation, estrogen levels, and...
The University of Illinois was awarded a $643,049 Project Grant under the National Institutes of Health's Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a physiomimetic model of the endometrioma lesion microenvironment. The objective is to investigate processes responsible for the initiation and invasion of endometriosis lesions, an estrogen-dependent disease affecting 10% of menstruating individuals. The research aims to uncover multicellular...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop new non-hormonal and non-opioid therapies for treating endometriosis-associated pain. The $254,610 grant funds research to: 1) identify inflammatory mediators and signaling pathways in macrophages activated by the neurotransmitter CGRP, which contributes to lesion formation and endometrial cell growth; 2)...
The National Institute of Child Health and Human Development (NICHD) awarded a $296,351 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Brooklyn Innoseq Inc. (doing business as Mamome) to develop and validate a non-invasive, microbiome-based diagnostic tool for the early detection of gestational diabetes mellitus (GDM). The key products and services to be delivered under this 1-year project include: 1) prospectively enrolling 250 pregnant women, collecting...
This federal Project Grant award for $131,085 was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to gain a better understanding of the contribution of uterine natural killer (UNK) cells to the pathobiology of endometriosis, a debilitating chronic disease affecting 10% of reproductive-age women worldwide. The proposed work aims to characterize the...
The National Institute of Child Health and Human Development (NICHD) has awarded a $423,985 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Illinois to develop a novel non-invasive monitoring system for detecting placental dysfunction and associated pregnancy complications. The funding will support research to utilize extracellular vesicles (EVs) circulating in maternal blood as biomarkers, using a "target recycling...
The National Institute of Child Health and Human Development (NICHD) awarded a Project Grant of $300,792.00 to Gynion, LLC on September 5, 2023 under the Child Health and Human Development Extramural Research program (CFDA 93.865). The funding will support the development and testing of MENORRX, a drug-device combination product intended to provide a non-invasive, cost-effective treatment for heavy menstrual bleeding (HMB). The proposed work aims to demonstrate the viability of the Yorkshire pig...